Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 Agonist and Bone: Effects of Exenatide on Bone Metabolism
2014-002124-27Phase 2Terminated
- Sponsor
- University Hospital Odense
- Start
- Oct 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of exenatide in Metabolic osteopathies, sponsored by University Hospital Odense. Primary endpoint: Change in bone formation marker P1NP. Started Oct 2014; status: terminated.
02
Drugs
exenatide
03
Conditions
Metabolic osteopathies
Beyond the preview
Go deeper on 2014-002124-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002124-27.